Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease
Clinical trial NCT02193191 · COMPLETED
Trial details
- NCT number
- NCT02193191
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-17
- Primary completion
- 2025-03-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.